Table 2. Tumour response to capecitabine/MMC.
| Best response | Number of patients | % |
|---|---|---|
| CR | 0 | 0 |
| PR | 5 | 15.2 |
| SD | 16 | 48.5 |
| PD | 12 | 36.4 |
| NE | 3 |
CR=complete response; PR=partial response; SD=stable disease; PD=progressive disease; NE=not evaluable.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.